115 related articles for article (PubMed ID: 23695260)
1. High-resolution crystal structure of the catalytic domain of human dual-specificity phosphatase 26.
Won EY; Xie Y; Takemoto C; Chen L; Liu ZJ; Wang BC; Lee D; Woo EJ; Park SG; Shirouzu M; Yokoyama S; Kim SJ; Chi SW
Acta Crystallogr D Biol Crystallogr; 2013 Jun; 69(Pt 6):1160-70. PubMed ID: 23695260
[TBL] [Abstract][Full Text] [Related]
2. Structural Insight into the Critical Role of the N-Terminal Region in the Catalytic Activity of Dual-Specificity Phosphatase 26.
Won EY; Lee SO; Lee DH; Lee D; Bae KH; Lee SC; Kim SJ; Chi SW
PLoS One; 2016; 11(9):e0162115. PubMed ID: 27583453
[TBL] [Abstract][Full Text] [Related]
3. Atomic structure of dual-specificity phosphatase 26, a novel p53 phosphatase.
Lokareddy RK; Bhardwaj A; Cingolani G
Biochemistry; 2013 Feb; 52(5):938-48. PubMed ID: 23298255
[TBL] [Abstract][Full Text] [Related]
4. Exploring binding sites other than the catalytic core in the crystal structure of the catalytic domain of MKP-4.
Jeong DG; Yoon TS; Jung SK; Park BC; Park H; Ryu SE; Kim SJ
Acta Crystallogr D Biol Crystallogr; 2011 Jan; 67(Pt 1):25-31. PubMed ID: 21206059
[TBL] [Abstract][Full Text] [Related]
5. A Review of DUSP26: Structure, Regulation and Relevance in Human Disease.
Thompson EM; Stoker AW
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466673
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of dual-specificity phosphatase 26 by ethyl-3,4-dephostatin: Ethyl-3,4-dephostatin as a multiphosphatase inhibitor.
Seo H; Cho S
Pharmazie; 2016 Apr; 71(4):196-200. PubMed ID: 27209699
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel dual-specificity phosphatase 26 inhibitors by a hybrid virtual screening approach based on pharmacophore and molecular docking.
Ren JX; Cheng Z; Huang YX; Zhao JF; Guo P; Zou ZM; Xie Y
Biomed Pharmacother; 2017 May; 89():376-385. PubMed ID: 28249240
[TBL] [Abstract][Full Text] [Related]
8. NSC-87877 inhibits DUSP26 function in neuroblastoma resulting in p53-mediated apoptosis.
Shi Y; Ma IT; Patel RH; Shang X; Chen Z; Zhao Y; Cheng J; Fan Y; Rojas Y; Barbieri E; Chen Z; Yu Y; Jin J; Kim ES; Shohet JM; Vasudevan SA; Yang J
Cell Death Dis; 2015 Aug; 6(8):e1841. PubMed ID: 26247726
[TBL] [Abstract][Full Text] [Related]
9. Protein phosphatase Dusp26 associates with KIF3 motor and promotes N-cadherin-mediated cell-cell adhesion.
Tanuma N; Nomura M; Ikeda M; Kasugai I; Tsubaki Y; Takagaki K; Kawamura T; Yamashita Y; Sato I; Sato M; Katakura R; Kikuchi K; Shima H
Oncogene; 2009 Feb; 28(5):752-61. PubMed ID: 19043453
[TBL] [Abstract][Full Text] [Related]
10. DUSP26 negatively affects the proliferation of epithelial cells, an effect not mediated by dephosphorylation of MAPKs.
Patterson KI; Brummer T; Daly RJ; O'Brien PM
Biochim Biophys Acta; 2010 Sep; 1803(9):1003-12. PubMed ID: 20347885
[TBL] [Abstract][Full Text] [Related]
11. Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastoma.
Shang X; Vasudevan SA; Yu Y; Ge N; Ludwig AD; Wesson CL; Wang K; Burlingame SM; Zhao YJ; Rao PH; Lu X; Russell HV; Okcu MF; Hicks MJ; Shohet JM; Donehower LA; Nuchtern JG; Yang J
Oncogene; 2010 Sep; 29(35):4938-46. PubMed ID: 20562916
[TBL] [Abstract][Full Text] [Related]
12. Dual-specificity phosphatase 26 protects against kidney injury caused by ischaemia-reperfusion through restraint of TAK1-JNK/p38-mediated apoptosis and inflammation of renal tubular epithelial cells.
Xiang H; Li Z; Li Y; Zheng J; Dou M; Xue W; Wu X
Toxicol Appl Pharmacol; 2024 Jun; 487():116954. PubMed ID: 38705402
[TBL] [Abstract][Full Text] [Related]
13. A distinct interaction mode revealed by the crystal structure of the kinase p38α with the MAPK binding domain of the phosphatase MKP5.
Zhang YY; Wu JW; Wang ZX
Sci Signal; 2011 Dec; 4(204):ra88. PubMed ID: 22375048
[TBL] [Abstract][Full Text] [Related]
14. Structural Insights into the Active Site Formation of DUSP22 in N-loop-containing Protein Tyrosine Phosphatases.
Lai CH; Chang CC; Chuang HC; Tan TH; Lyu PC
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33053837
[TBL] [Abstract][Full Text] [Related]
15. The DUSP26 phosphatase activator adenylate kinase 2 regulates FADD phosphorylation and cell growth.
Kim H; Lee HJ; Oh Y; Choi SG; Hong SH; Kim HJ; Lee SY; Choi JW; Su Hwang D; Kim KS; Kim HJ; Zhang J; Youn HJ; Noh DY; Jung YK
Nat Commun; 2014; 5():3351. PubMed ID: 24548998
[TBL] [Abstract][Full Text] [Related]
16. The family-wide structure and function of human dual-specificity protein phosphatases.
Jeong DG; Wei CH; Ku B; Jeon TJ; Chien PN; Kim JK; Park SY; Hwang HS; Ryu SY; Park H; Kim DS; Kim SJ; Ryu SE
Acta Crystallogr D Biol Crystallogr; 2014 Feb; 70(Pt 2):421-35. PubMed ID: 24531476
[TBL] [Abstract][Full Text] [Related]
17. A novel amplification target, DUSP26, promotes anaplastic thyroid cancer cell growth by inhibiting p38 MAPK activity.
Yu W; Imoto I; Inoue J; Onda M; Emi M; Inazawa J
Oncogene; 2007 Feb; 26(8):1178-87. PubMed ID: 16924234
[TBL] [Abstract][Full Text] [Related]
18. NSC-87877, inhibitor of SHP-1/2 PTPs, inhibits dual-specificity phosphatase 26 (DUSP26).
Song M; Park JE; Park SG; Lee DH; Choi HK; Park BC; Ryu SE; Kim JH; Cho S
Biochem Biophys Res Commun; 2009 Apr; 381(4):491-5. PubMed ID: 19233143
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of a novel mitogen-activated protein kinase phosphatase, SKRP1.
Wei CH; Ryu SY; Jeon YH; Yoon MY; Jeong DG; Kim SJ; Ryu SE
Proteins; 2011 Nov; 79(11):3242-6. PubMed ID: 21989941
[No Abstract] [Full Text] [Related]
20. A conserved motif in JNK/p38-specific MAPK phosphatases as a determinant for JNK1 recognition and inactivation.
Liu X; Zhang CS; Lu C; Lin SC; Wu JW; Wang ZX
Nat Commun; 2016 Mar; 7():10879. PubMed ID: 26988444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
